21 CFR 211.188
Prepared for each batch, include complete information
- Inspections citing it: 1,450
- Of those classified, ended OAI: 28%
- Last cited: FY2026
Inspections Citing It by Fiscal Year
Sites in and outside the US, FY2017 to Oct 20, 2026.
Paragraphs Cited
As FDA posts them, all years.
- 211.188
- 586 · Prepared for each batch, include complete information
- 211.188(b)(8)
- 179 · Labeling control records including specimens or copies
- 211.188(b)
- 164 · Batch production and Batch Control Record Requirements
- 211.188(a)
- 72 · Accurate reproduction
- 211.188(b)(11)
- 71 · Identification of persons involved, each significant step
- 211.188(b)(2)
- 62 · Identity of major equipment and lines used
- 211.188(b)(7)
- 57 · Actual yield, % of theoretical yield
- 211.188(b)(12)
- 55 · Investigations made into any unexplained discrepancy
Regulation Text
eCFR did not answer; open it on eCFRRecently Cited Sites
Newest inspections citing this section; each opens the site- Steril-Gene Life Sciences Private LtdIndia · Aug 12, 2026
- Hetero Labs Ltd. Unit VIIndia · Jun 26, 2026
- Nowcos Co., Ltd.Unknown · Jun 19, 2026
- Safecor Health, LLCUnited States · Jun 12, 2026
- The Flower Remedy LLCUnited States · Jun 12, 2026
- GVS TM, IncUnited States · May 1, 2026
- Hyland's Consumer Health Inc.United States · Apr 22, 2026
- Gallant Pet IncUnited States · Feb 27, 2026
- J. Strickland and CoUnited States · Nov 20, 2025
- SV Labs CorporationUnited States · Oct 23, 2025
- Minaris Regenerative Medicine, LLCUnited States · Sep 29, 2025
- Sparsha Pharma Usa IncUnited States · Sep 4, 2025
Counts are inspections with posted citations that cite any paragraph of the section, once per inspection, from FDA's Data Dashboard. OAI share is over inspections FDA finally classified. Text from eCFR, the official online CFR. FDA Data Dashboard and eCFR